Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study
The ONTIME study investigated whether early post-stroke abobotulinumtoxinA injection delays appearance or progression of upper limb spasticity (ULS) symptoms. ONTIME (NCT02321436) was a 28-week, exploratory, double-blind, randomized, placebo-controlled study of abobotulinumtoxinA 500U in patients wi...
Main Authors: | Rosales, Raymond, Balcaitiene, Jovita, Berard, Hugues, Maisonobe, Pascal, Goh, Khean, Kumthornthip, Witsanu, Mazlan, Mazlina, Abdul Latif, Lydia, Delos Santos, Mary, Chotiyarnwong, Chayaporn, Tanvijit, Phakamas, Nuez, Odessa, Kong, Keng |
---|---|
Format: | Article |
Published: |
MDPI
2018
|
Subjects: |
Similar Items
-
Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study
by: Raymond L Rosales, et al.
Published: (2018-06-01) -
Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper limb spasticity (ONTIME pilot)
by: Keng He Kong, et al.
Published: (2017-06-01) -
Long-term follow-up of intravesical abobotulinumtoxinA (Dysport®) injections in women with idiopathic detrusor overactivity
by: Mohammad Sajjad Rahnama'i, et al.
Published: (2024-01-01) -
Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies
by: Alberto Esquenazi, et al.
Published: (2020-09-01) -
Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment
by: Jörg Wissel, et al.
Published: (2020-02-01)